雄激素与男性肾移植受者移植后糖尿病发生的关系:一项前瞻性研究的事后分析
该研究对243例男性肾移植受者进行事后分析,采用液相色谱-串联质谱法测定雄激素水平,中位随访5.3年。结果显示,双氢睾酮和睾酮水平与移植后糖尿病(PTDM)风险呈独立负相关,低雄激素水平可能是男性肾移植受者发生PTDM的新型可干预危险因素。
要点
- 双氢睾酮和睾酮水平越高,男性肾移植受者发生PTDM的风险越低。
- 低雄激素水平可能是男性肾移植受者PTDM的可干预危险因素。
- 该关联独立于血糖和HbA1c,提示雄激素对β细胞健康可能有直接作用。
核心结论
- 低雄激素水平可能是男性肾移植受者发生移植后糖尿病的新型潜在可干预危险因素。
研究设计与样本
- 前瞻性单中心队列研究的事后分析,纳入243例移植肾功能稳定≥1年的成年男性肾移植受者。
- 采用液相色谱-串联质谱法测定雄激素水平,PTDM依据美国糖尿病协会标准定义。
主要发现
- 随访5.3(3.7-5.8)年期间,28例(11.5%)受者发生PTDM。
- 双氢睾酮三分位组PTDM发生率分别为19%、12%和4%(P=0.008)。
- 双氢睾酮作为连续变量与PTDM风险负相关(HR 0.31,95%CI 0.16-0.59,P<0.001),独立于血糖和HbA1c。
- 睾酮作为连续变量与PTDM风险负相关(HR 0.32,95%CI 0.15-0.68,P=0.003),独立于血糖和HbA1c。
临床怎么用
- 在男性肾移植受者中,可关注雄激素水平作为PTDM风险评估的潜在指标。
- 低雄激素水平可能成为未来干预靶点,但尚需进一步研究验证。
局限性
- 本研究为事后分析,结果需前瞻性研究验证。
- 单中心设计可能限制结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Posttransplantation diabetes mellitus (PTDM) effects up to 30% of all kidney transplant recipients (KTR). Recent studies in mice found that sufficient androgen levels are necessary for β-cell health and adequate insulin secretion. This raises the question whether a similar relationship might be present in KTR. Hence, we hypothesized that dihydrotestosterone and testosterone are associated with the development of PTDM in male KTR. RESEARCH DESIGN AND METHODS: We conducted a post hoc analyses of a prospective single-center cohort study including adult male KTR with a functioning graft ≥1 year posttransplantation. Androgen levels were assessed by liquid chromatography-tandem mass spectrometry. Development of PTDM was defined according to the American Diabetes Association's criteria. RESULTS: We included 243 male KTR (aged 51 ± 14 years), with a median dihydrotestosterone 0.9 (0.7-1.3) nmol/L and testosterone of 12.1 (9.4-15.8) nmol/L. During 5.3 (3.7-5.8) years of follow-up, 28 KTR (11.5%) developed PTDM. A clear association was observed, as 15 (19%), 10 (12%), and 3 (4%) male KTR developed PTDM in the respective tertiles of dihydrotestosterone (P = 0.008). In Cox regression analyses, both dihydrotestosterone and testosterone as continuous variables were inversely associated with the risk to development PTDM, independent of glucose and HbA1c (hazard ratio [HR] 0.31 [95% CI 0.16-0.59], P < 0.001; and HR 0.32 [95% CI 0.15-0.68], P = 0.003, respectively). CONCLUSIONS: Our results suggest that low androgen levels are a novel potential modifiable risk factor for the development of PTDM in male KTR.
引用
- Stam SP, Sokooti S, Eisenga MF, et al. Androgens and Development of Posttransplantation Diabetes Mellitus in Male Kidney Transplant Recipients: A Post Hoc Analysis of a Prospective Study. Diabetes Care. 2021. PMID: 34610923. doi:10.2337/dc21-0237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。